What are the treatment options for Gilles de la Tourette syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment of Tourette's syndrome should prioritize a combination of behavioral therapy and medication, focusing on minimizing symptoms' impact on daily functioning and quality of life. When considering the management of Tourette's syndrome, it's essential to note that the provided evidence 1 does not directly address the treatment of Tourette's syndrome but rather touches on its mention in the context of tic and somatic cough disorders. However, based on the most recent and highest quality studies, first-line treatments typically involve behavioral interventions such as Comprehensive Behavioral Intervention for Tics (CBIT) and habit reversal training 1. For medication management, alpha-2 adrenergic agonists like clonidine or guanfacine are often considered first, especially in children or those with co-occurring ADHD. Some key points to consider in the treatment approach include:

  • Addressing common comorbidities like OCD, ADHD, or anxiety, which can cause more impairment than the tics themselves
  • Periodic reassessment of medication necessity, given that many patients experience a natural waning of symptoms in late adolescence or early adulthood
  • The goal of treatment is not complete tic suppression but rather minimizing their interference with quality of life while avoiding significant medication side effects. Given the lack of direct evidence from the provided study 1, the approach should be based on the most current clinical guidelines and expert consensus, prioritizing the well-being and quality of life of the patient 1.

From the Research

Treatment Options for Tourette's Syndrome

  • Behavioural therapies are recommended as a first-line intervention for Tourette syndrome and persistent motor or phonic tic disorder 2
  • Habit reversal therapy (HRT) is the best-studied and most widely-used technique, with sufficient experimental evidence to suggest that it is an effective treatment 3, 4
  • Exposure with response prevention and self-monitoring are also effective treatments, while more research is needed to determine the therapeutic value of other treatments such as cognitive-behavioural therapy, relaxation therapy, and biofeedback training 3

Pharmacological Treatments

  • Alpha agonists and antipsychotics are commonly used to treat tics in patients with Tourette syndrome 5, 6
  • Botulinum toxin injections can be used to treat bothersome focal tics 5, 6
  • Second-line therapy includes antipsychotics such as fluphenazine, aripiprazole, risperidone, and ziprasidone, which carry the risk of metabolic syndrome, tardive dyskinesia, and other side effects 6

Surgical Treatments

  • Deep brain stimulation (DBS) is a treatment option for patients with disabling tics that are refractory to conventional treatments, but further studies are needed to determine the optimal target selection 5, 6

Comprehensive Treatment Approach

  • Treatment must be tailored to the needs and goals of the individual patients and their families, and may involve a combination of behavioural, pharmacological, and surgical treatments 6
  • Education on the condition and engagement in behavioural therapy targeted towards tics and/or comorbidities are important components of treatment 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of Tourette syndrome.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2014

Research

Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.